Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,546 | -34,951 | -17,655 | -9,725 | 6,843 |
| Depreciation Amortization | 1,043 | 697 | 353 | 1,593 | 1,224 |
| Accounts receivable | 2,096 | 2,096 | 1,117 | -1,559 | -3,119 |
| Accounts payable and accrued liabilities | 1,533 | 587 | 343 | -1,593 | 1,104 |
| Other Working Capital | 3,404 | 1,119 | -223 | -4,248 | -2,154 |
| Other Operating Activity | 3,203 | 1,375 | 808 | 13,314 | 10,645 |
| Operating Cash Flow | $-43,267 | $-29,077 | $-15,257 | $-2,218 | $14,543 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 31,923 | 13,221 | -777 | 32,508 | 30,017 |
| PPE Investments | -155 | -65 | N/A | -278 | -47 |
| Investing Cash Flow | $31,768 | $13,156 | $-777 | $32,230 | $29,970 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 365 | 301 | N/A | 2,746 | 2,663 |
| Financing Cash Flow | $365 | $301 | $N/A | $2,746 | $2,663 |
| Beginning Cash Position | 59,413 | 59,413 | 59,413 | 26,655 | 26,655 |
| End Cash Position | 48,279 | 43,793 | 43,379 | 59,413 | 73,831 |
| Net Cash Flow | $-11,134 | $-15,620 | $-16,034 | $32,758 | $47,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,267 | -29,077 | -15,257 | -2,218 | 14,543 |
| Capital Expenditure | -155 | -65 | N/A | -278 | -47 |
| Free Cash Flow | -43,422 | -29,142 | -15,257 | -2,496 | 14,496 |